The Gross Margin of Tarsus Pharmaceuticals Inc (TARS) is 92.99%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 92.99% |
| 2023-12-31 | 90.87% |
| 2022-12-31 | 96.28% |
| 2021-12-31 | 96.35% |